약물감시사업과 약물유해반응에 대한 인식도 조사
A Survey on Attitude and Awareness of Health-Care Professionals Regarding Pharmacovigilance System and Experience for Adverse Drug Reaction (ADR) from a Single University Hospital
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objective: To study the attitudes and awareness of healthcare professionals (physicians, pharmacists, nurses and others) toward the Pharmacovigilance system and experience for adverse drug reactions (ADRs) from a Single University Hospital in Deajeon. Methods: A survey was performed using a structured questionnaire involving 360 health-care professionals at the hospital between 1st November and 16th November, 2012. Results: Sixty-five percent (n=235) of all respondents were experienced incidences of ADRs for their patients and 55.8% (n=201) knew the ADR Spontaneous Reporting System in the hospital. However, three-fourths (n=273, 75.8%) of respondents did not know the existence of the Korean Association of Regional Pharmacovigilance Centers (KARP) and 61.7% (n=222) were unaware of the obligation of ADR report from KFDA in cases of serious ADRs. About 83% (n=299) answered that the electronic ADR report system of the hospital was helpful while their work and most (n=336, 93.3%) agreed on the necessaries of the promotion and education about ADR. Conclusion: Seventy-five percent (n=271) of respondents wanted to continue the work for evaluation and feedback for ADRs reported in the hospital. However, the barriers to reporting ADR were; inconvenient ADR reporting system and the lack of time to report ADRs. This study showed that the easier ADR reporting system and education and promotion about ADRs for health-care providers are needed to improve the ADR reporting.
Abstract
Objective: To study the attitudes and awareness of healthcare professionals (physicians, pharmacists, nurses and others) toward the Pharmacovigilance system and experience for adverse drug reactions (ADRs) from a Single University Hospital in Deajeon. Methods: A survey was performed using a structured questionnaire involving 360 health-care professionals at the hospital between 1st November and 16th November, 2012. Results: Sixty-five percent (n=235) of all respondents were experienced incidences of ADRs for their patients and 55.8% (n=201) knew the ADR Spontaneous Reporting System in the hospital. However, three-fourths (n=273, 75.8%) of respondents did not know the existence of the Korean Association of Regional Pharmacovigilance Centers (KARP) and 61.7% (n=222) were unaware of the obligation of ADR report from KFDA in cases of serious ADRs. About 83% (n=299) answered that the electronic ADR report system of the hospital was helpful while their work and most (n=336, 93.3%) agreed on the necessaries of the promotion and education about ADR. Conclusion: Seventy-five percent (n=271) of respondents wanted to continue the work for evaluation and feedback for ADRs reported in the hospital. However, the barriers to reporting ADR were; inconvenient ADR reporting system and the lack of time to report ADRs. This study showed that the easier ADR reporting system and education and promotion about ADRs for health-care providers are needed to improve the ADR reporting.
참고문헌 (21)
- Safety of Medicines: A guide to detecting and reporting adverse drug reactions, "World Health Organization", WHO, ~ (2002)
- Davies EC, "Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes", PLoS One, 4, pp.e4439~ (2009)
- Ernst FR, "Drug-related morbidity and mortality: updating the cost-of-illness model", J Am Pharm Assoc, 41(2), pp.192~199 (2001)
- Uppsala Monitoring Centre, "WHO Collaborating Centre for International Drug Monitoring, EQUUS: Safety Monitoring of Medicinal Products Guidelines for setting up and running a Pharmacovigilance Centre", ~ (2000)
- Bennett CL, "Evaluation of serious adverse drug reaction", Arch Intern Med, 167, pp.1041~1049 (2007)
- Moore TJ, "Serious adverse events reported to the Food and Drug Administration, 1995-2005", Arch Intern Med, 167, pp.1752~1759 (2007)
- "Website"[URL]
- DICKSON, M, "Pharmaceutical use and expenditure for cardiovascular disease and stroke: A study of 12 OECD countries", Organisation for Economic Co-operation and Development, ~ (2003)
- KUIJPERS, M. A. J, "Relationship between polypharmacy and underprescribing", British Journal of Clinical Pharmacology, 65, pp.130~133 (2007)
- WIEDENMAYER, K, "Rational use of medicines, In Managing pharmaceuticals in international health", pp.141~152 (2004), Birkhauser
- WINDMEIJER, F, "Pharmaceutical promotion and GP prescription behaviour", Heath Economics, 15, pp.5~18 (2006)
- Roughead E, "Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners", Pharmacoepidemiol Drug Saf, 16, pp.797~803 (2007)
- Kim HK, "A Survey on introduction of pharmacovigilance specialist certification system", Journal of pharmacoepidemiology and risk management, 3, pp.36~45 (2010)
- Figuerias A, "An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial", JAMA, 296, pp.1086~1093 (2006)
- Kelly M, "Factors influencing adverse drug reaction reporting in New South Wlaes teaching hospitals", Drug Saf, 22, pp.161~168 (2004)
- Nissen SE, K W, "Rosiglitazone Revisited : An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality", Arch Intern Med, 170, pp.1191~1201 (2010)
- 유기연, "식품의약품안전청 약물유해반응 보고자료 분석", 한국임상약학회지, 21(2), pp.138~144 (2011), 한국임상약학회
- 최윤희, "3차 병원에서 보고된 의약품 부작용 현황 조사와 약물 부작용 관리를 위한 약사의 인식도 조사", 한국임상약학회지, 13(2), pp.72~81 (2003), 한국임상약학회
- 임혜리, "원내 약물부작용 보고 유형별 분석", 병원약사회지, 28(2), pp.1~9 (2011), 한국병원약사회
- 유기연, "식품의약품안전청에 보고된 심혈관계 약물유해반응의 특성 분석", 한국임상약학회지, 22(1), pp.41~46 (2012), 한국임상약학회